These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

307 related articles for article (PubMed ID: 27378395)

  • 1. Inhibition of transglutaminase 2 reduces efferocytosis in human macrophages: Role of CD14 and SR-AI receptors.
    Eligini S; Fiorelli S; Tremoli E; Colli S
    Nutr Metab Cardiovasc Dis; 2016 Oct; 26(10):922-30. PubMed ID: 27378395
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Macrophage SR-BI mediates efferocytosis via Src/PI3K/Rac1 signaling and reduces atherosclerotic lesion necrosis.
    Tao H; Yancey PG; Babaev VR; Blakemore JL; Zhang Y; Ding L; Fazio S; Linton MF
    J Lipid Res; 2015 Aug; 56(8):1449-60. PubMed ID: 26059978
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transglutaminase activity regulates atherosclerotic plaque composition at locations exposed to oscillatory shear stress.
    Matlung HL; Neele AE; Groen HC; van Gaalen K; Tuna BG; van Weert A; de Vos J; Wentzel JJ; Hoogenboezem M; van Buul JD; VanBavel E; Bakker EN
    Atherosclerosis; 2012 Oct; 224(2):355-62. PubMed ID: 22921425
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Retinoic acid-induced tissue transglutaminase and apoptosis in vascular smooth muscle cells.
    Ou H; Haendeler J; Aebly MR; Kelly LA; Cholewa BC; Koike G; Kwitek-Black A; Jacob HJ; Berk BC; Miano JM
    Circ Res; 2000 Nov; 87(10):881-7. PubMed ID: 11073883
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transglutaminase 2 is involved in amyloid-beta
    Currò M; Gangemi C; Giunta ML; Ferlazzo N; Navarra M; Ientile R; Caccamo D
    Amino Acids; 2017 Mar; 49(3):659-669. PubMed ID: 27864692
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TGM2 inhibition attenuates ID1 expression in CD44-high glioma-initiating cells.
    Fu J; Yang QY; Sai K; Chen FR; Pang JC; Ng HK; Kwan AL; Chen ZP
    Neuro Oncol; 2013 Oct; 15(10):1353-65. PubMed ID: 23877317
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transglutaminase 2 expression levels regulate sensitivity to cystamine plus TRAIL-mediated apoptosis.
    Jang JH; Park JS; Lee TJ; Kwon TK
    Cancer Lett; 2010 Jan; 287(2):224-30. PubMed ID: 19632032
    [TBL] [Abstract][Full Text] [Related]  

  • 8.
    Pan Z; Dumas EK; Lawrence C; Pate L; Longobardi S; Wang X; James JA; Kovats S; Farris AD
    Int J Mol Sci; 2019 Mar; 20(5):. PubMed ID: 30866434
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Daidzein enhances efferocytosis via transglutaminase 2 and augmentation of Rac1 activity.
    Yen JH; Yang DJ; Chen MC; Yi-Ying W; Hsieh YF; Cheng YM; Huang WN; Szondy Z; Tsay GJ
    Mol Immunol; 2014 Aug; 60(2):135-42. PubMed ID: 24859791
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of Transglutaminase 2 activity increases cisplatin cytotoxicity in a model of human hepatocarcinoma chemotherapy.
    Meshram DD; Pike CVS; Coussons PJ
    Eur J Pharmacol; 2017 Nov; 815():332-342. PubMed ID: 28943101
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transcriptional control of transglutaminase 2 expression in mouse apoptotic thymocytes.
    Sándor K; Daniel B; Kiss B; Kovács F; Szondy Z
    Biochim Biophys Acta; 2016 Aug; 1859(8):964-74. PubMed ID: 27262403
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induction of transglutaminase 2 by a liver X receptor/retinoic acid receptor alpha pathway increases the clearance of apoptotic cells by human macrophages.
    Rébé C; Raveneau M; Chevriaux A; Lakomy D; Sberna AL; Costa A; Bessède G; Athias A; Steinmetz E; Lobaccaro JM; Alves G; Menicacci A; Vachenc S; Solary E; Gambert P; Masson D
    Circ Res; 2009 Aug; 105(4):393-401. PubMed ID: 19628791
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efferocytosis capacities of blood monocyte-derived macrophages in systemic sclerosis.
    Ballerie A; Lescoat A; Augagneur Y; Lelong M; Morzadec C; Cazalets C; Jouneau S; Fardel O; Vernhet L; Jégo P; Lecureur V
    Immunol Cell Biol; 2019 Mar; 97(3):340-347. PubMed ID: 30426551
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transglutaminase Is Required for Epidermal Squamous Cell Carcinoma Stem Cell Survival.
    Fisher ML; Keillor JW; Xu W; Eckert RL; Kerr C
    Mol Cancer Res; 2015 Jul; 13(7):1083-94. PubMed ID: 25934691
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Involvement of tissue transglutaminase in endothelin 1-induced hypertrophy in cultured neonatal rat cardiomyocytes.
    Li X; Wei XL; Meng LL; Chi MG; Yan JQ; Ma XY; Jia YS; Liang L; Yan HT; Zheng JQ
    Hypertension; 2009 Oct; 54(4):839-44. PubMed ID: 19635990
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Leukocyte transglutaminase 2 expression limits atherosclerotic lesion size.
    Boisvert WA; Rose DM; Boullier A; Quehenberger O; Sydlaske A; Johnson KA; Curtiss LK; Terkeltaub R
    Arterioscler Thromb Vasc Biol; 2006 Mar; 26(3):563-9. PubMed ID: 16410462
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adenosine produced from adenine nucleotides through an interaction between apoptotic cells and engulfing macrophages contributes to the appearance of transglutaminase 2 in dying thymocytes.
    Sándor K; Pallai A; Duró E; Legendre P; Couillin I; Sághy T; Szondy Z
    Amino Acids; 2017 Mar; 49(3):671-681. PubMed ID: 27236567
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Loss of transglutaminase 2 sensitizes for diet-induced obesity-related inflammation and insulin resistance due to enhanced macrophage c-Src signaling.
    Sághy T; Köröskényi K; Hegedűs K; Antal M; Bankó C; Bacsó Z; Papp A; Stienstra R; Szondy Z
    Cell Death Dis; 2019 Jun; 10(6):439. PubMed ID: 31165747
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Amplification of transglutaminase 2 enhances tumor-promoting inflammation in gastric cancers.
    Cho SY; Oh Y; Jeong EM; Park S; Lee D; Wang X; Zeng Q; Qin H; Hu F; Gong H; Liu X; Zhang G; Na D; Lee J; Chae J; Suh YS; Kong SH; Lee HJ; Kim JI; Park H; Zhang C; Yang HK; Lee C
    Exp Mol Med; 2020 May; 52(5):854-864. PubMed ID: 32467608
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transglutaminase 2 accelerates vascular calcification in chronic kidney disease.
    Chen NX; O'Neill K; Chen X; Kiattisunthorn K; Gattone VH; Moe SM
    Am J Nephrol; 2013; 37(3):191-8. PubMed ID: 23466870
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.